EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cathepsin K cleavage of angiopoietin-2 creates detrimental Tie2 antagonist fragments in sepsis

Takashi Suzuki, Erik Loyde, Sara Chen, Valerie Etzrodt, Temitayo O Idowu, Amanda J Clark, Marie Christelle Saade, Brenda Mendoza Flores, Shulin Lu, Gabriel Birrane, Vamsidhara Vemireddy, Benjamin Seeliger und 2 weitere

Journal of Clinical Investigation · 15.04.2025 · 135 (8)

DOI: 10.1172/jci174135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.03.2025. Verfasst von Takashi Suzuki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Angiopoietin-2, Receptor, TIE-2, Sepsis, Cathepsin K. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIA NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated angiopoietin-2 is associated with diverse inflammatory conditions, including sepsis, a leading global cause of mortality. During inflammation, angiopoietin-2 antagonizes the endothelium-enriched receptor Tie2 to destabilize the vasculature. In other contexts, angiopoietin-2 stimulates Tie2. The basis for context-dependent antagonism remains incompletely understood. Here, we show that inflammation-induced proteolytic cleavage of angiopoietin-2 converts this ligand from Tie2 agonist to antagonist. Conditioned media from stimulated macrophages induced endothelial angiopoietin-2 secretion. Unexpectedly, this was associated with reduction of the 75 kDa full-length protein and appearance of new 25 and 50 kDa C-terminal fragments. Peptide sequencing proposed cathepsin K as a candidate protease. Cathepsin K was necessary and sufficient to cleave angiopoietin-2. Recombinant 25 and 50 kDa angiopoietin-2 fragments (cANGPT2 25 and cANGPT2 50 ) bound and antagonized Tie2. Cathepsin K inhibition with the phase 3 small-molecule inhibitor odanacatib improved survival in distinct murine sepsis models. Full-length angiopoietin-2 enhanced survival in endotoxemic mice administered odanacatib and, conversely, increased mortality in the drug’s absence. Odanacatib’s benefit was reversed by heterologous cANGPT2 25 . Septic humans accumulated circulating angiopoietin-2 fragments, which were associated with adverse outcomes. These results identify cathepsin K as a candidate marker of sepsis and a proteolytic mechanism for the conversion of angiopoietin-2 from Tie2 agonist to antagonist, with therapeutic implications for inflammatory conditions associated with angiopoietin-2 induction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiopoietin-2Receptor, TIE-2SepsisCathepsin KAnimalsHumansMiceProteolysisMale

Stichwörter der Autor:innen

Endothelial cellsInflammationVascular biology

Substanzen

Angiopoietin-2Receptor, TIE-2Cathepsin KANGPT2 protein, humanTEK protein, humanTek protein, mouse

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Center for Vascular Biology Research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Pediatric Nephrology, Department of Pediatrics, UT Southwestern Medical Center and Children's Medical Center, Dallas, Texas, USA.
  • Division of Experimental Medicine, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
  • Biomedical Research in End-Stage and Obstructive Lung Disease, Hannover Medical School, German Center for Lung Research, Hannover, Germany.

Förderung

  • NIDDK NIH HHS
  • NIA NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Suzuki, T., Loyde, E., Chen, S., Etzrodt, V., Idowu, T. O., Clark, A. J., Saade, M. C., Flores, B. M., Lu, S., Birrane, G., Vemireddy, V., Seeliger, B., David, S., & Parikh, S. M. (2025). Cathepsin K cleavage of angiopoietin-2 creates detrimental Tie2 antagonist fragments in sepsis. Journal of Clinical Investigation, 135(8). https://doi.org/10.1172/jci174135

Vancouver

Suzuki T, Loyde E, Chen S, Etzrodt V, Idowu TO, Clark AJ, et al. Cathepsin K cleavage of angiopoietin-2 creates detrimental Tie2 antagonist fragments in sepsis. Journal of Clinical Investigation. 2025;135(8). doi:10.1172/jci174135

BibTeX
@article{Suzuki2025,
  author = {Suzuki, Takashi and Loyde, Erik and Chen, Sara and Etzrodt, Valerie and Idowu, Temitayo O and Clark, Amanda J and Saade, Marie Christelle and Flores, Brenda Mendoza and Lu, Shulin and Birrane, Gabriel and Vemireddy, Vamsidhara and Seeliger, Benjamin and David, Sascha and Parikh, Samir M},
  title = {Cathepsin K cleavage of angiopoietin-2 creates detrimental Tie2 antagonist fragments in sepsis},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {8},
  doi = {10.1172/jci174135}
}
Kostenlos starten →